Skip to main content
ELVN logo

ELVN · Enliven Therapeutics, Inc. · Debt

Track ELVN — free
$58.02 -1.35 (-2.27%)
Market Cap
$4.35B
Shares
73.27M

Debt Profile

Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.

Debt data is being processed. Please check back later.
Key facts CIK 1672619 CUSIP 29337E102 13F (30d) 167 filings 167 filers Visit website Investor relations